Ken Griffin Accelerate Diagnostics, Inc Put Options Transaction History

Citadel Advisors LLC

  • $483 Billion
  • Q2 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$0.64 - $1.03 $384 - $618
600 Added 6.45%
9,900 $8,000
Q1 2023

May 15, 2023
SELL
$0.46 - $0.77 $17,710 - $29,645
-38,500 Reduced 80.54%
9,300 $6,000
Q4 2022

Feb 14, 2023
BUY
$0.51 - $17.1 $7,854 - $263,340
15,400 Added 47.53%
47,800 $33,000
Q3 2022

Nov 14, 2022
SELL
$1.01 - $17.0 $661,045 - $11.1 Million
-654,500 Reduced 95.28%
32,400 $49,000

Others Institutions Holding AXDX

# of Institutions
3
Shares Held
549K
Call Options Held
0
Put Options Held
0
View Full List

About Accelerate Diagnostics, Inc

AXDX Quotes by TradingView
  • Ticker AXDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 99,059,904
  • Market Cap $191M
  • Description
  • Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...
More about AXDX
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email